Both in Pharmaceuticals
ArriVent BioPharma vs Immix Biopharma
Over the past year AVBP returned −26.0% and IMMX returned +111.8%; their daily moves had a correlation of 0.29.
AVBP −26.0% IMMX +111.8%Growth of $1, one year, split-adjusted
| Metric | AVBP | IMMX |
|---|---|---|
| Price | $13.02 | $7.71 |
| Market cap | $642.0M | $639.2M |
| Today | −2.47% | +6.20% |
| 1 month | −54.3% | −23.9% |
| 6 months | −56.4% | −19.4% |
| Year to date | −35.3% | +47.4% |
| 1 year | −30.5% | +102.9% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $373.1M | $232.1M |
| Dividend yield | — | — |
| Volatility (60d) | 154.4% | 69.4% |
| Short % of float | 20.3% | 22.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).